Market Overview

RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Medical Devices

0.2700 0.01 (3.97%)

Data as of May 24, 2020

Prev. Close 0.2597
Price Open
Volume 0
Day's Range -
52 Wk Range 3 - 5.5
50 Day Moving Avg. 4.42
PE Ratio 0.173148
Shares Outstanding 5.48M
Market Cap 1.48M

Trade RSLS stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

ReShape Lifesciences Announces 1-For-120 Reverse Stock Split Effective Nov. 12 Benzinga NewsdeskMon, 11 Nov 2019 13:53:30 -0400
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering Shanthi RexalineWed, 14 Aug 2019 07:50:27 -0400
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Shanthi RexalineWed, 07 Aug 2019 07:34:05 -0400
Reshape Lifesciences Q1 EPS $(0.54) Down From $(0.36) YoY, Sales $3.074M Up From $139K YoY Benzinga NewsdeskMon, 20 May 2019 16:23:11 -0400
ReShape Lifesciences FY18 Sales $2.8M Up From $2.3M YoY Benzinga NewsdeskMon, 01 Apr 2019 16:09:42 -0400
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Shanthi RexalineSat, 30 Mar 2019 09:32:40 -0400
48 Biggest Movers From Friday Lisa LevinMon, 31 Dec 2018 06:18:32 -0400
Mid-Afternoon Market Update: Dow Rises 150 Points; Obalon Therapeutics Shares Plunge Lisa LevinFri, 28 Dec 2018 15:21:21 -0400
26 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 28 Dec 2018 13:43:17 -0400
Mid-Day Market Update: Crude Oil Up Over 1%; Quantum Shares Spike Higher Lisa LevinFri, 28 Dec 2018 13:18:02 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences Announces First Quarter 2020 Financial and Operational Results ACCESSWIREMay 14, 2020
ReShape Lifesciences Announces Fourth Quarter and Full Year 2019 Financial Results ACCESSWIREMar 26, 2020
ReShape Lifesciences, Inc. to Host Earnings Call ACCESSWIREMar 26, 2020
ReShape Lifesciences to Host Fourth Quarter and Full Year 2019 Conference Call on March 26, 2020 ACCESSWIREMar 23, 2020
ReShape Lifesciences Announces Third Quarter 2019 Financial Results ACCESSWIRENov 14, 2019
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split ACCESSWIRENov 11, 2019
ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019 ACCESSWIRENov 07, 2019
ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R) ACCESSWIRENov 05, 2019
ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer ACCESSWIREOct 30, 2019
ReShape Lifesciences Announces Attendance and Presentation at Obesity Week 2019 ACCESSWIREOct 17, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences' (RSLS) CEO Bart Bandy on Q3 2019 Results - Earnings Call Transcript Seeking AlphaNov 14, 2019
ReShape Lifesciences reports Q3 results Seeking AlphaNov 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q2 2019 Results - Earnings Call Transcript Seeking AlphaAug 14, 2019
ReShape Lifesciences reports Q2 results Seeking AlphaAug 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q1 2019 Results - Earnings Call Transcript Seeking AlphaMay 20, 2019
ReShape Lifesciences reports Q1 results Seeking AlphaMay 20, 2019
ReShape Lifesciences Inc.'s (RSLS) CEO Dan Gladney on Q4 2018 Results - Earnings Call Transcript Seeking AlphaApr 01, 2019
ReShape Lifesciences reports Q4 results Seeking AlphaApr 01, 2019
ReShape Lifesciences announces $2M convertible note financing Seeking AlphaMar 29, 2019
New CEO at ReShape Lifesciences Seeking AlphaMar 26, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

74.05% Positive

Earnings View Earnings

Q1 2020	EST	Actual	Surprise
EPS:	Expected 2020-05-14
Rev:	Expected 2020-05-14

	EST	Actual	Surprise
EPS:	Expected
Rev:	Expected

Company Profile

Read More

Visit company website

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses

Brokerage Center

Compare All Online Brokerages